|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Operating expenses | |||||
| Research and development, net of tax credits | |||||
| General and administrative | |||||
| Commercial | |||||
| Loss from operations | |||||
| Interest income | |||||
| Interest expense | |||||
| Net loss and comprehensive loss | |||||
| Weighted average number of shares and pre-funded warrants outstanding, basic (in shares) | |||||
| Weighted average number of shares and pre-funded warrants outstanding, diluted (in shares) | |||||
| Net loss per share, basic (in dollars per share) | |||||
| Net loss per share, diluted (in dollars per share) | |||||
Loading...
